The morbidity from osteoporotic fractures for people with a disability is considerable because of the increased risk of medical complications, loss of independence and mobility, and prolonged hospitalization. The frequency with which low bone mineral density occurs in people with a disability is now well recognized, and professionals have a greater awareness of the need to investigate bone mineral density levels with a view to preventing fragility fractures. After patients with osteoporosis are identified, the challenge is to treat them appropriately. This article reviews the physical and pharmacologic measures that have been researched in the prevention and treatment of low bone mineral density in people with a disability.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.pmrj.2010.10.001 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!